Familial Dysalbuminemic Hyperthyroxinemia that was Inappropriately Treated with Thiamazole Due to Pseudo-thyrotoxic Symptoms

Autor: Takahiro Fukaishi, Yoshihito Hara, Yoshihiro Sekiguchi
Rok vydání: 2017
Předmět:
Adult
medicine.medical_specialty
medicine.medical_treatment
Graves' disease
Hyperpituitarism
Thyroid Gland
SITSH
Thyrotropin
Case Report
030209 endocrinology & metabolism
Diagnosis
Differential

03 medical and health sciences
chemistry.chemical_compound
Exon
0302 clinical medicine
Antithyroid Agents
Internal medicine
Internal Medicine
medicine
Humans
Codon
Serum Albumin
Ultrasonography
Methimazole
Transition (genetics)
business.industry
Antithyroid agent
Thyroid
Hyperthyroxinemia
Familial Dysalbuminemic

General Medicine
medicine.disease
Graves Disease
thiamazole
medicine.anatomical_structure
Endocrinology
chemistry
Familial dysalbuminemic hyperthyroxinemia
030220 oncology & carcinogenesis
Mutation
familial dysalbuminemic hyperthyroxinemia (FDH)
Female
Differential diagnosis
business
Cytosine
Zdroj: Internal Medicine
ISSN: 1349-7235
0918-2918
DOI: 10.2169/internalmedicine.8619-16
Popis: We herein report the case of a Japanese woman with familial dysalbuminemic hyperthyroxinemia (FDH) who was initially diagnosed with Graves' disease. Direct genomic sequencing revealed a guanine to cytosine transition in the second nucleotide of codon 218 in exon 7 of the albumin gene, which then caused a proline to arginine substitution. She was finally diagnosed with FDH, which did not require treatment. FDH is - superficially - an uncommon cause of syndrome of inappropriate secretion of thyrotropin (SITSH) in Japan. A misdiagnosis of pseudo-hyperthyroidism will lead to inappropriate treatment. Thus, physicians should strongly note the possibility of FDH as a differential diagnosis of SITSH.
Databáze: OpenAIRE